Abstract: A 60-year-old woman was diagnosed with esophageal small cell carcinoma in October 2004 and received chemotherapy. However, the tumor grew gradually and multiple bone metastases occurred. Anorexia, nausea, emesis, numbness in both hands, and disturbed consciousness developed at the end of January 2006, and the patient was admitted to Fukushima Medical University Hospital. Abdominal pain, marked hypercalcemia and hyperamylasemia were noted and the patient was diagnosed with severe acute pancreatitis. Because the level of blood parathyroid hormone-related protein was elevated, we considered that esophageal small cell carcinoma caused human hypercalcemia of malignancy and that metastatic bone tumors caused local osteolytic hypercalcemia, eventually leading to severe acute pancreatitis. This is an extremely rare case of esophageal small cell carcinoma associated with hypercalcemia causing severe acute pancreatitis.
We report a case of esophageal small cell carcinoma in whi ch human hyperca lcemia of malignancy (I-II-IM) was probably caused by primary tumor and metastatic tumors, and local osteo lytic hypercalcemia (LOH) by metastatic bone tumors, eventually leading to severe acute pancreatitis. I-II-IM is one of the paraneoplastic syndromes caused by parathyroid hormone-related protein (PTHrP)-producing tumor. The known sites of the primary foci of this tumor incl ude the lungs, ovar y, and esophagus, and its hi stological type is mainl y squamous cell carcinoma l) . Primary esophageal sma ll cell carcinoma, which accounts for 1% to 4.7% of a ll esophageal tumors 2 ,3) , is rarer than esophageal squamous cell ca rcinoma. Thus, pancreatitis due to primary esophageal small cell carcinoma is extremely rare.
CASE REPORT
A 60 -year-old wo man experi enced difficulty in svva llowing solid food around September 2004. In October 2004, she presented to a clinic, where esophago-gastroduodenoscopy (EGD) showed two tumors, a type-2 tumor, accord ing to the Guidelines for Clinical and Pa thologic Studies on Carcinoma establi shed by the J apan Esophageal Society, 37 cm from the superior incisor teeth (Fig. lA) and a submucosal tumor at the gastric cardia (Fig. IB) . Imm ediately she was referred to Fukushim a Medical University Hospita l. The esophageal tumor was diagnosed as small cell carcinoma by the hi stologica l examinati on of EGD biopsy specimens (Fig. 2) ; its depth of invasion was measured using endoscopi c ultrasonograph y (EUS) , which showed invasion into the adventiti a (Fig. 3A) . The submucosal tumor at the gastric cardia appeared as a tumor originating from the proper muscular la yer on EUS (Fig.  3B ). Endoscopic ultrasonograph y-guided fine-needl e aspiration biopsy (EUS-F NA)
A B F ig. 1. Esophago-gastro-du odenosco py. (A) A type-2 adva nced tumor was fo und 37 cm awa y from th e superi o r inciso r teeth in the lower thorac ic esophag us. (E) A su bmucosa l tumo r was found at th e gastri c cardia (arrow). was performed, and the tumor was a lso diagnosed as sma ll cell carcinoma ( Fig. 4A ; Fig. 4B ). Because no sign of small cell carcin oma was found in the neighboring regions including the lungs, we considered th at esophageal carcinoma was the prim ar y focus, and that it metastasized to the gastric cardia. Since she was diagnosed with Stage IV primary esophagea l small cell carcinoma, she was treated by chemother apy according to the treatment regimen for small cell carcinom a of the lung in the absence of an established standard treatment for that of the esophagus. From December 2004, 5 cycles of Irinotecan (CPT -ll)/ Cisplatin (CDDP) were adm inistered, reducing both the primary focus and the gastri c metastasis for a whi le. However, because they grew slowly aga in, the therapy was cha nged to 4 cycles of Etoposide (VP-16)/ CDDP and 3 cyc les of Docetaxel, but in va in; the primary tum or still grew, and the number of metastatic mediastinal lymph nodes increased, and so from November 2005, 2 cycles of TS-l were given. Nevertheless, a norexia, backache, nausea, and emesis occurred in late J an uary 2006. Bone scintigraphy revealed an abnormal accumulation of radi oactivity in the lumba r vertebrae ( hyperamylasemia, and renal dysfunction. The levels of tumor ma rkers, ca rcin oembryonic antigen (CEA) (13,164.8 ng/ ml, normal < 4.9 ng/ mJ), carbohydrate a ntigen 19-9 (CA19 -9) (45.4 U/ ml, normal < 37 U/ m!), and nuron specific enolase ( ISE) (27.8 ng/ ml , normal < 10.0 ng/ ml) wer e elevated, and the level of bone metastasis ma rker pyridinol ine cross-lin ked carboxy termina l telopeptide of type 1 co llagen (lCTP) (18.2 ng/ ml , normal < 4.5 ng/ ml ) was also elevated. Intact PTH was mark edly decreased to 2.0 pg/ ml (normal 6.5-59.7 pg/ ml) , whereas PTHrP was increased to 16.1 pmol/I (normal < 1.1 pm ol/ l). Because numbness in both hands, disturbed consc iollsness, and a norex ia were considered to be attributed to hypercalcemia, massive F ig. 7. Plain CT of the abdomen. Diffuse swelling of the pancreas, low abso rbance a rea in the pa ncreatic head, and effusion and increased adipose tissue co ncentration in t he retroperitonea l space in and below t he inferior poles of kidneys were seen (a rrow).
fluid replacement was performed, and diuretic, bi sphosphonate, and calcitonin were administered. However, disturbed consciousness persisted, r a ising suspicion of brain metastasis. Pla in MRI of the bra in (Fig. 6 ) revealed irregular tumors in the temporal and occipital cortical bone a nd bone marrow, but no tumor suspici ous of metastasis in the brain parenchyma. Acute pancreatitis was a lso suspected because of abdominal pain and hyperamylasem ia. Therefore, abdomina l computed tomography (CT) was performed without contrast medium ; rena l dysfunction was noted, and there was a history of allergy to contrast medium (Fig. 7) . It showed diffuse swelling of the pancreas, a low absorbance area in the pancreatic head, a nd effusion extending from the r etr operitoneal space to the inferior poles of both kidneys. It also showed pleural effusion, ascites, multiple metastatic tumors in the li ver, metastatic bone tumors in the spine, and multiple swoll en lymph nodes around the aorta. These findings led to the diagnosis of severe acute pancreatitis with a scor e of 3, which was treated conservatively wi th gabexate mesilate, urinastatin, and antibiotics wi thout success. Renal dysfunction and acidosis worsened, and disseminated intervascul ar coagulati on (DIC) developed. The patient di ed on F ebruary 8, 2006 .
DISCUSSION
Esophageal small cell carcinoma was first reported in 1952 by McKeown as oatcell carcinoma 4 ) .
In Japan, approx imately 200 cases have been recorded in Japana Centra R evuo Medicina since 1983. In add ition, primary esophageal small cell carcinoma is so rare that it accounts for only 1% to 4.7% of all esophagea l tum ors 2 ,3) This carcinoma spreads widely lymphatically or hematogenously from early stages; it is often advanced when detected. Bayer et al. 3) reported that in the 134 cases of esophageal small cell carcinoma they saw or found in the literature, the average life expectancy after diagnosis was 5.3 months, and that the one-year survival rate was 10%. Thus, the prognosis of esophageal small cell carcinoma is extremely poor, and no standard treatment has been established. Our patient was treated by chemotherapy according to the treatment scheme for small cell carcinoma of the lung, but died 16 months after diagnosis.
Acute pancreatitis was the direct cause of death in this patient. Although acute pancreatitis is known to result from alcohol consumption and gallstones, it may also be caused by hypercalcemia. A well-known disease that causes hypercalcemia is primary hyperparathyroidism whose major clinical symptoms are produced by nephrolithiasis and bone lesions. Acute pancreatitis associated with primary hyperparathyroidism was first reported in 1957 by Cope et at. 5) , and the frequency of the association has been reported to be 1% or less 6 • 7 ). On the other hand, acute pancreatitis associated with pseudohyperparathyroidism caused by esophageal carcinoma is extremely rare. We were able to find no case in Japana Centra Revuo Medicina or MEDLINE during the period of 1983 to 2006. Since our patient had no history of alcohol consumption, no gallstones revealed on imaging study and no increase in hepatic and biliary enzymes, alcohol and gallstones were excluded as possible causes of acute pancreatitis. However, her blood test showed marked hypercalcemia. These findings led us to consider that hypercalcemia was the cause of acute pancreatitis.
Several possible mechanisms have been proposed for the development of acute pancreatitis in patients with hyperparathyroidism, including the following four: 1) pancreatitis is prone to occur because hypercalcemia raises the serum trypsin levelS) ; 2) pancreatitis occurs because hypercalcemia causes calcification and stenosis in the pancreatic parenchyma and duct; 3) pancreatitis occurs because blood flow is reduced by PTH -induced microembolization or by damage to the pancreas by PTH itself 9 ); and 4) pancreatic necrosis occurs because both protein that should be secreted into the pancreas and protein catabolic enzyme accumulate owing to the impairment of pancreatic exocrine function with increase in intracellular calcium lO ) . Although none of these mechanisms have been fully understood, they may also be involved in the development of acute pancreatitis in patients with hypercalcemia associated with small cell carcinoma.
Hypercalcemia is often seen in malignant tumors, especially esophageal carcinoma. Tachimori et at. 11), examining 382 cases of esophageal carcinoma, reported that hypercalcemia was present in 38% of recurrent nonexcision cases. Malignancy-associated hypercalcemia is presumed to be caused by cytokines produced by tumor cells or the immune cells activated by tumor cells 12 ). It is roughly divided into two syndromes, HHM and LOH. HHM is caused by excessive production of PTHrP, a PTH-like hormone, by tumors13) and is considered to account for 80% or more of the cases of malignancy-associated hypercalcemia 1'). LOH is presumed to be caused by bone metastasis of tumor cells and multiple myeloma, because tumor cells in bones produce local factors including cytokines. In this patient, because examination on admission showed multiple bone metastases and a high level of blood PTHrP, the hypercalcemia was considered to be HHM, although the possibility of LOH contributing to it could not be ruled out. It is noteworthy that there are papers reporting that HHM is caused by squamous cell carcinomas of the esophagus, lung, skin, head, neck and kidney, but, as for small cell carcinomas, there are very few papers reporting that HHM is caused by those of the ovary15-17) and prostate1 8 ). FereidoonP9) reports a 63-year-old woman who developed esophageal carcinoma associated with hypercalcemia. The carcinoma consisted of two components, squamous cell carcinoma and pleomorphic small cells. The hypercalcemia was assumed to be due to PTHrP, and immunohistochemistry showed that it was caused not by squamous cell carcinoma, but by pleomorphic small cells alone. We have found reports of acute pancreatitis caused by hypercalcemia in small cell carcinomas of the ovary20) and lung2l), but not of the esophagus in Japana Centra Revuo Medicina or MEDLINE during the period between 1983 and 2006.
Thus, this is an extremely rare case of esophageal small cell carcinoma associated with hypercalcemia causing severe acute pancreatitis.
